The Himachal Pradesh High Court has granted Boehringer Ingelheim an interim injunction against Eris Lifesciences, preventing the manufacture and sale of Empagliflozin during the suit. The case provides insights into the judicial approach towards pharmaceutical patent disputes in India.
Read more about Boehringer secures Patent Injunction for its Diabetes Drug – EmpagliflozinIndian Patent and Design Statistics 2024 (May 24th to 31st)
This report analyses Indian patent and design statistics for 24th to 31st May 2024, highlighting weekly and yearly trends, city-wise data, and industrial design registrations. The information is compiled by BananaIP’s expert team with a focus on clarity and factual accuracy.
Read more about Indian Patent and Design Statistics 2024 (May 24th to 31st)Patent examination should not kill the scientific temper of an inventor
The Madras High Court set aside the rejection of Industeel France’s patent application, stressing the need for fair and consistent patent examination. The judgment highlights the importance of protecting inventors’ scientific temper and ensuring time-bound decisions under Indian patent law.
Read more about Patent examination should not kill the scientific temper of an inventorNew claims, Old claims, and Claim Amendments: Section 59 of the Patents Act
This post examines a Madras High Court ruling on Section 59 of the Patents Act regarding patent claim amendments. The Court clarified procedural requirements and applicant rights during the patent examination process in India.
Read more about New claims, Old claims, and Claim Amendments: Section 59 of the Patents ActRenounced Riches, Not Rights! Court upholds Sanyasi’s copyrights
The Delhi High Court held that a sanyasi can own and assign copyright in India, as seen in the case of Srila Prabhupada and the Bhaktivedanta Book Trust. The judgment clarifies that copyright is not automatically relinquished by renunciation, ensuring statutory protection for assigned works.
Read more about Renounced Riches, Not Rights! Court upholds Sanyasi’s copyrightsIndian Patent and Design Statistics 2024 (May 17th to 24th)
This report analyses Indian patent and design statistics for May 17th to 24th, 2024, focusing on applications, grants, and city-wise trends. Authored by BananaIP, it offers a neutral and factual overview for legal and IP professionals.
Read more about Indian Patent and Design Statistics 2024 (May 17th to 24th)Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)
The Madras High Court clarified the interpretation of Section 3c regarding patent eligibility of monoclonal antibodies in India. The Court held that synthetic antibodies may be patentable if they demonstrate novelty or technical advancement.
Read more about Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)Authors, Copyright and Royalty Share : The Calcutta High Court gives clarity
The Calcutta High Court has clarified the scope of authors’ royalty rights under Indian copyright law, affirming protections introduced by the 2012 amendment. The judgment ensures that authors of literary and musical works receive royalties, irrespective of copyright ownership transfers or the date of creation.
Read more about Authors, Copyright and Royalty Share : The Calcutta High Court gives clarityAll set for VOMISET : Court restores trademark and allows renewal beyond deadline
The Bombay High Court restored Indi Pharma’s VOMISET trademark, permitting late renewal due to non-receipt of statutory notice. The order clarifies rights under Section 25(3) of the Trade Marks Act, 1999, and mandates timely Registrar action on such applications.
Read more about All set for VOMISET : Court restores trademark and allows renewal beyond deadlineCourt criticizes Patent Office for using outdated CRI Guidelines
The Madras High Court condemned the Patent Office’s reliance on outdated CRI guidelines in Microsoft’s patent application case, highlighting the significance of technical effect in computer related inventions. The court allowed the appeal and directed a new evaluation.
Read more about Court criticizes Patent Office for using outdated CRI Guidelines